Hypermarcas (OTCMKTS:HYPMY) Issues Quarterly Earnings Results

Hypermarcas (OTCMKTS:HYPMY) announced its earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.01, Zacks reports. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%.

Hypermarcas Price Performance

Shares of OTCMKTS:HYPMY traded down $0.03 during midday trading on Thursday, hitting $4.13. The company had a trading volume of 3,851 shares, compared to its average volume of 7,909. The business’s 50-day simple moving average is $4.10 and its 200-day simple moving average is $4.36. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of 8.60 and a beta of 0.70. Hypermarcas has a twelve month low of $3.71 and a twelve month high of $5.50.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. Zacks Research raised Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.